Bifidobacterium bifidum BBi32 and Reduced Urea Level

Doses used in studies

CFU/day: 30 billion (median 30 billion, IQR 30 billion–30 billion) — 1 study

Safety in these studies

Overall tolerabilityReported
daily BBi32 administration (3 × 10^10 CFU) was well tolerated, with no hematological or hepatic abnormalities.
from: Clinical Safety and Tolerability of Bifidobacterium bifidum BBi32: An 8-Week Randomized, D

1 of 1 paper

Clinical Safety and Tolerability of Bifidobacterium bifidum BBi32: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial With Genomic and In Vitro Corroboration.